Side-by-side comparison of AI visibility scores, market position, and capabilities
Mexico City shared equity homeownership platform partnering with HSBC and Citibanamex for non-debt housing access; YC W23 $500K targeting 9M+ housing unit gap with $1M revenue competing with Infonavit for Mexican homebuyer financing.
Holacasa is a Mexico City-based home equity financing platform — backed by Y Combinator (W23) with $500,000 raised from YC, Goodwater Capital, Invariantes Fund, 1517 Fund, and Accel — providing Mexican homebuyers with shared equity financing that enables access to non-debt homeownership without the credit score, down payment, and debt-to-income ratio requirements that exclude the majority of Mexican families from traditional mortgage programs, generating $1 million in revenue in 2024 with a 9-person team through partnerships with 10+ major Mexican banks including HSBC, Citibanamex, and Banorte. Founded in 2022, Holacasa targets the Mexican housing affordability crisis where 9+ million housing units are needed but 70%+ of the population lacks access to formal mortgage credit.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.